Report Detail
COVID-19 Impact on Global AI Drug Development Market Report, History and Forecast 2015-2026, Breakdown Data by Companies, Key Regions, Types and Application
- RnM4258429 |
- 27 November, 2020 |
- Global |
- 119 Pages |
- QYResearch |
- Service & Software
Market Analysis and Insights: Global AI Drug Development Market
The research report studies the AI Drug Development market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.
The global AI Drug Development market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global AI Drug Development Scope and Segment
The global AI Drug Development market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global AI Drug Development market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2015-2026.
by Type, the market is primarily split into
Drug Design
Drug Synthesis
Other
by Application, this report covers the following segments
Tumor
Nervous System
Other
Global AI Drug Development market: regional analysis, the major regions covered in the report are:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
The report lists the major players in the regions and their respective market share on the basis of global revenue. It also explains their strategic moves in the past few years, investments in product innovation, and changes in leadership to stay ahead in the competition. This will give the reader an edge over others as a well-informed decision can be made looking at the holistic picture of the market.
The AI Drug Development key players in this market include:
Insilico Medicine
Cyclica
XtalPi Inc.
Exscientia Limited
AiCure, LLC
Atomwise
Biovista Inc.
Breg，Inc.
Numerate
Cloud Pharmaceuticals
IBM
NuMedii
BenevolentAI
Lam Therapeutics
1 Market Overview of AI Drug Development
- 1.1 AI Drug Development Market Overview
- 1.1.1 AI Drug Development Product Scope
- 1.1.2 Market Status and Outlook
- 1.2 Global AI Drug Development Market Size Overview by Region 2015 VS 2020 VS 2026
- 1.3 Global AI Drug Development Market Size by Region (2015-2026)
- 1.4 Global AI Drug Development Historic Market Size by Region (2015-2020)
- 1.5 Global AI Drug Development Market Size Forecast by Region (2021-2026)
- 1.6 Key Regions, AI Drug Development Market Size YoY Growth (2015-2026)
- 1.6.1 North America AI Drug Development Market Size YoY Growth (2015-2026)
- 1.6.2 Europe AI Drug Development Market Size YoY Growth (2015-2026)
- 1.6.3 Asia-Pacific AI Drug Development Market Size YoY Growth (2015-2026)
- 1.6.4 Latin America AI Drug Development Market Size YoY Growth (2015-2026)
- 1.6.5 Middle East & Africa AI Drug Development Market Size YoY Growth (2015-2026)
2 AI Drug Development Market Overview by Type
- 2.1 Global AI Drug Development Market Size by Type: 2015 VS 2020 VS 2026
- 2.2 Global AI Drug Development Historic Market Size by Type (2015-2020)
- 2.3 Global AI Drug Development Forecasted Market Size by Type (2021-2026)
- 2.4 Drug Design
- 2.5 Drug Synthesis
- 2.6 Other
3 AI Drug Development Market Overview by Application
- 3.1 Global AI Drug Development Market Size by Application: 2015 VS 2020 VS 2026
- 3.2 Global AI Drug Development Historic Market Size by Application (2015-2020)
- 3.3 Global AI Drug Development Forecasted Market Size by Application (2021-2026)
- 3.4 Tumor
- 3.5 Nervous System
- 3.6 Other
4 Global AI Drug Development Competition Analysis by Players
- 4.1 Global AI Drug Development Market Size by Players (2015-2020)
- 4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in AI Drug Development as of 2019)
- 4.3 Date of Key Manufacturers Enter into AI Drug Development Market
- 4.4 Global Top Players AI Drug Development Headquarters and Area Served
- 4.5 Key Players AI Drug Development Product Solution and Service
- 4.6 Competitive Status
- 4.6.1 AI Drug Development Market Concentration Rate
- 4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
- 5.1 Insilico Medicine
- 5.1.1 Insilico Medicine Profile
- 5.1.2 Insilico Medicine Main Business
- 5.1.3 Insilico Medicine AI Drug Development Products, Services and Solutions
- 5.1.4 Insilico Medicine AI Drug Development Revenue (US$ Million) & (2015-2020)
- 5.1.5 Insilico Medicine Recent Developments
- 5.2 Cyclica
- 5.2.1 Cyclica Profile
- 5.2.2 Cyclica Main Business
- 5.2.3 Cyclica AI Drug Development Products, Services and Solutions
- 5.2.4 Cyclica AI Drug Development Revenue (US$ Million) & (2015-2020)
- 5.2.5 Cyclica Recent Developments
- 5.3 XtalPi Inc.
- 5.5.1 XtalPi Inc. Profile
- 5.3.2 XtalPi Inc. Main Business
- 5.3.3 XtalPi Inc. AI Drug Development Products, Services and Solutions
- 5.3.4 XtalPi Inc. AI Drug Development Revenue (US$ Million) & (2015-2020)
- 5.3.5 Exscientia Limited Recent Developments
- 5.4 Exscientia Limited
- 5.4.1 Exscientia Limited Profile
- 5.4.2 Exscientia Limited Main Business
- 5.4.3 Exscientia Limited AI Drug Development Products, Services and Solutions
- 5.4.4 Exscientia Limited AI Drug Development Revenue (US$ Million) & (2015-2020)
- 5.4.5 Exscientia Limited Recent Developments
- 5.5 AiCure, LLC
- 5.5.1 AiCure, LLC Profile
- 5.5.2 AiCure, LLC Main Business
- 5.5.3 AiCure, LLC AI Drug Development Products, Services and Solutions
- 5.5.4 AiCure, LLC AI Drug Development Revenue (US$ Million) & (2015-2020)
- 5.5.5 AiCure, LLC Recent Developments
- 5.6 Atomwise
- 5.6.1 Atomwise Profile
- 5.6.2 Atomwise Main Business
- 5.6.3 Atomwise AI Drug Development Products, Services and Solutions
- 5.6.4 Atomwise AI Drug Development Revenue (US$ Million) & (2015-2020)
- 5.6.5 Atomwise Recent Developments
- 5.7 Biovista Inc.
- 5.7.1 Biovista Inc. Profile
- 5.7.2 Biovista Inc. Main Business
- 5.7.3 Biovista Inc. AI Drug Development Products, Services and Solutions
- 5.7.4 Biovista Inc. AI Drug Development Revenue (US$ Million) & (2015-2020)
- 5.7.5 Biovista Inc. Recent Developments
- 5.8 Breg，Inc.
- 5.8.1 Breg，Inc. Profile
- 5.8.2 Breg，Inc. Main Business
- 5.8.3 Breg，Inc. AI Drug Development Products, Services and Solutions
- 5.8.4 Breg，Inc. AI Drug Development Revenue (US$ Million) & (2015-2020)
- 5.8.5 Breg，Inc. Recent Developments
- 5.9 Numerate
- 5.9.1 Numerate Profile
- 5.9.2 Numerate Main Business
- 5.9.3 Numerate AI Drug Development Products, Services and Solutions
- 5.9.4 Numerate AI Drug Development Revenue (US$ Million) & (2015-2020)
- 5.9.5 Numerate Recent Developments
- 5.10 Cloud Pharmaceuticals
- 5.10.1 Cloud Pharmaceuticals Profile
- 5.10.2 Cloud Pharmaceuticals Main Business
- 5.10.3 Cloud Pharmaceuticals AI Drug Development Products, Services and Solutions
- 5.10.4 Cloud Pharmaceuticals AI Drug Development Revenue (US$ Million) & (2015-2020)
- 5.10.5 Cloud Pharmaceuticals Recent Developments
- 5.11 IBM
- 5.11.1 IBM Profile
- 5.11.2 IBM Main Business
- 5.11.3 IBM AI Drug Development Products, Services and Solutions
- 5.11.4 IBM AI Drug Development Revenue (US$ Million) & (2015-2020)
- 5.11.5 IBM Recent Developments
- 5.12 NuMedii
- 5.12.1 NuMedii Profile
- 5.12.2 NuMedii Main Business
- 5.12.3 NuMedii AI Drug Development Products, Services and Solutions
- 5.12.4 NuMedii AI Drug Development Revenue (US$ Million) & (2015-2020)
- 5.12.5 NuMedii Recent Developments
- 5.13 BenevolentAI
- 5.13.1 BenevolentAI Profile
- 5.13.2 BenevolentAI Main Business
- 5.13.3 BenevolentAI AI Drug Development Products, Services and Solutions
- 5.13.4 BenevolentAI AI Drug Development Revenue (US$ Million) & (2015-2020)
- 5.13.5 BenevolentAI Recent Developments
- 5.14 Lam Therapeutics
- 5.14.1 Lam Therapeutics Profile
- 5.14.2 Lam Therapeutics Main Business
- 5.14.3 Lam Therapeutics AI Drug Development Products, Services and Solutions
- 5.14.4 Lam Therapeutics AI Drug Development Revenue (US$ Million) & (2015-2020)
- 5.14.5 Lam Therapeutics Recent Developments
6 North America
- 6.1 North America AI Drug Development Market Size by Country
- 6.2 United States
- 6.3 Canada
7 Europe
- 7.1 Europe AI Drug Development Market Size by Country
- 7.2 Germany
- 7.3 France
- 7.4 U.K.
- 7.5 Italy
- 7.6 Russia
- 7.7 Nordic
- 7.8 Rest of Europe
8 Asia-Pacific
- 8.1 Asia-Pacific AI Drug Development Market Size by Region
- 8.2 China
- 8.3 Japan
- 8.4 South Korea
- 8.5 Southeast Asia
- 8.6 India
- 8.7 Australia
- 8.8 Rest of Asia-Pacific
9 Latin America
- 9.1 Latin America AI Drug Development Market Size by Country
- 9.2 Mexico
- 9.3 Brazil
- 9.4 Rest of Latin America
10 Middle East & Africa
- 10.1 Middle East & Africa AI Drug Development Market Size by Country
- 10.2 Turkey
- 10.3 Saudi Arabia
- 10.4 UAE
- 10.5 Rest of Middle East & Africa
11 AI Drug Development Market Dynamics
- 11.1 Industry Trends
- 11.2 Market Drivers
- 11.3 Market Challenges
- 11.4 Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Disclaimer
Summary:
Get latest Market Research Reports on COVID-19 Impact on Global AI Drug Development. Industry analysis & Market Report on COVID-19 Impact on Global AI Drug Development is a syndicated market report, published as COVID-19 Impact on Global AI Drug Development Market Report, History and Forecast 2015-2026, Breakdown Data by Companies, Key Regions, Types and Application. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global AI Drug Development market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
